Polypeptide, human vacuolar H+ -ATPase C subunit 42 and polynucleotide encoding it
US6994996B1 · kind B1 · utility
0Cited by
1References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 27, 2000 |
| Grant date | Feb 7, 2006 |
| Priority date | — |
| Expiry date | Oct 2, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N9/14
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention discloses a novle human vacuolar H+-ATPase C subunit 42 and a polynucleotide encoding it. The invention also concerns a process of producing the polypeptide by recombinant DNA techniques. Methods are also disclosed for treating many diseases, e.g. malignant tumors, hemopathies, HIV infections, immune diseases and inflammations utilizing the ploypeptide. The invention discloses antagonists of the polypeptide and therapeutics comprising the same. The invention also discloses the uses of the polynucleotide, which encodes the human vacuolar H+-ATPase C subunit 42.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.